Estrogen reduces vascular endothelial growth factor164 expression in the mouse nucleus paraventricularis of the hypothalamus

Neuroscience Letters

Volumn 333, Issue 3, 2002, Pages 199-202

  Sibug, R M ^a,b   Helmerhorst, F M ^b   Tijssen, A M I ^a   De Kloet, E R ^a   De Koning, J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adrenalectomy; Estrogen; Hippocampus; In situ hybridization; Nucleus paraventricularis; Vascular endothelial growth factor164 expression

Indexed keywords

ESTRADIOL BENZOATE; MESSENGER RNA; VASCULOTROPIN;

ADRENALECTOMY; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THALAMUS MIDLINE NUCLEUS;

ADRENALECTOMY; ANIMALS; AUTORADIOGRAPHY; CORTICOSTERONE; ESTRADIOL; ESTROGENS; FEMALE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; OVARIECTOMY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RADIOIMMUNOASSAY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0037195540     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01112-6     Document Type: Article

References (23)

1. Auerbach W., Auerbach R. Angiogenesis inhibition: a review. Pharmacol. Ther. 63:1994;265-311.
2. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 114:1992;521-532.
3. De Kloet E.R. Corticosteroids, stress, and aging. Ann. N.Y. Acad. Sci. 663:1992;357-371.
4. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett. 127:2002;217-224.
5. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA.
6. Hall J.M., McDonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 140:1999;5566-5578.
7. Harada S., Nagy J.A., Sullivan K.A., Thomas K.A., Endo N., Rodan G.A., Rodan S.B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Invest. 93:1994;2490-2496.
8. Hyder S.M., Huang J.C., Nawaz Z., Boettger-Tong H., Makela S., Chiappetta C., Stancel G.M. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ. Health Perspect. 108(Suppl 5):2000;785-790.
9. Jin K.L., Mao X.O., Nagayama T., Goldsmith P.C., Greenberg D.A. Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3′-kinase/Akt signaling by global cerebral ischemia in the rat. Neuroscience. 100:2000;713-717.
10. Lee M.Y., Ju W.K., Cha J.H., Son B.C., Chun M.H., Kang J.K., Park C.K. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci. Lett. 265:1999;107-110.
11. Meirer R., Gurunluoglu R., Siemionow M. Neurogenic perspective on vascular endothelial growth factor: review of the literature. J. Reconstr. Microsurg. 17:2001;625-630.
12. Mueller M.D., Vigne J.L., Minchenko A., Lebovic D.I., Leitman D.C., Taylor R.N. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. USA. 97:2000;10972-10977.
13. Nauck M., Karakiulakis G., Perruchoud A.P., Papakonstantinou E., Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur. J. Pharmacol. 341:1998;309-315.
14. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., Madri J.A., Ment L.R. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277:2002;11410-11415.
15. Patt S., Danner S., Theallier-Janko A., Breier G., Hottenrott G., Plate K.H., Cervos-Navarro J. Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat. Neurosci. Lett. 252:1998;199-202.
16. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
17. Sibug R.M., Compaan J.C., Meijer O.C., Van der G.J., Olivier B., De Kloet E.R. Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels. Eur. J. Pharmacol. 353:1998;207-214.
18. Silverman W.F., Krum J.M., Mani N., Rosenstein J.M. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 90:1999;1529-1541.
19. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:1999;5731-5740.
20. Sordello S., Bertrand N., Plouet J. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem. Biophys. Res. Commun. 251:1998;287-290.
21. Sugihara T., Wadhwa R., Kaul S.C., Mitsui Y. A novel alternatively spliced form of murine vascular endothelial growth factor, VEGF 115. J. Biol. Chem. 273:1998;3033-3038.
22. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J. Neuroendocrinol. 14:2002;506-513.
23. Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M., Gustafsson J.A. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. USA. 97:2000;5936-5941.